Compounds > n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine
Page last updated: 2024-09-03

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and bromodeoxycytidine

n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with bromodeoxycytidine in 1 studies

Compound Research Comparison

Studies
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)		Trials
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)		Recent Studies (post-2010)
(n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine)		Studies
(bromodeoxycytidine)		Trials
(bromodeoxycytidine)		Recent Studies (post-2010) (bromodeoxycytidine)
8021105211

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harapanhalli, RS; Howell, RW; Narra, VR; Rao, DV; Sastry, KS1

Other Studies

1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and bromodeoxycytidine

ArticleYear
Radiotoxicity of some iodine-123, iodine-125 and iodine-131-labeled compounds in mouse testes: implications for radiopharmaceutical design.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1992, Volume: 33, Issue:12

    Topics: Amphetamines; Animals; Bromodeoxycytidine; Cell Survival; Deoxycytidine; Dose-Response Relationship, Radiation; Drug Design; Idoxuridine; Injections; Iodine Radioisotopes; Iodobenzenes; Iofetamine; Male; Mice; Sperm Head; Subcellular Fractions; Testis

1992